HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

heptakis(2,6- O- dimethyl)beta- cyclodextrin

stimulant for Bordetella pertussis Phase I
Also Known As:
2,6-beta-O-dimethylcyclodextrin; 2,6-di-O-methyl-beta-cyclodextrin; DM-beta-CD; DM-beta-CyD; DMbeta-Cyd; HKDBC; MEDCD cpd; dimethyl-beta-cyclodextrin; heptakis(2,6-di-O-methyl)-beta-cyclodextrin; beta-Cyclodextrin, 2A,2B,2C,2D,2E,2F,2G,6A,6B,6C,6D,6E,6F,6G-tetradeca-O-methyl-
Networked: 9 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Choshi, Tominari: 1 article (11/2006)
2. Fujimori, Shiho: 1 article (11/2006)
3. Hibino, Satoshi: 1 article (11/2006)
4. Ichihara, Yoshitatsu: 1 article (11/2006)
5. Murata, Natsuko: 1 article (11/2006)
6. Nemoto, Hideo: 1 article (11/2006)
7. Nobuhiro, Junko: 1 article (11/2006)
8. Oikawa, Tsutomu: 1 article (11/2006)
9. Sato, Yoshio: 1 article (11/2006)
10. Suzuki, Hiroto: 1 article (11/2006)

Related Diseases

1. Photoallergic Dermatitis (Photoallergy)
2. Edema (Dropsy)
3. Hemolysis
4. Body Weight (Weight, Body)
5. Pulmonary Embolism

Related Drugs and Biologics

1. Therapeutic Uses
2. Carrageenan
3. heptakis(2,6- O- dimethyl)beta- cyclodextrin
4. Hydrogels
5. Paclitaxel (Taxol)
6. Solutions
7. Insulin (Novolin)
8. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
9. Dihydrotachysterol (AT 10)
10. Chlorpromazine (Thorazine)

Related Therapies and Procedures

1. Subcutaneous Injections